title: [Anticomplement treatment of PNH in the era of Eculizumab: problems and outlook].
authors.affiliation: Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
authors.forename: Zhijie
authors.initials: Z
authors.lastname: Wu
authors.affiliation: Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
authors.forename: Fengkui
authors.initials: F
authors.lastname: Zhang
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003169:Complement Inactivator Proteins / Q000627:therapeutic use*; D006457:Hemoglobinuria, Paroxysmal / Q000628:therapy*; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003169:Complement Inactivator Proteins; C012749:anticomplement; C481642:eculizumab